Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Cyclically Adjusted Book per Share: €1.18 (As of Mar. 2026)


STU:08HH Shanghai Fosun Pharmaceutical (Group) Co Ltd STU:08HH
71 GF Score
Price €1.80
GF Value €2.23
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share?

Shanghai Fosun Pharmaceutical (Group) Co STU:08HH +2.62% 71 Cyclically Adjusted Book per Share is €1.18 as of Mar. 2026. GuruFocus rates STU:08HH with a GF Score™ of 71/100 and a GF Value™ of €2.23 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted book value per share for the three months ended in Mar. 2026 was €2.310. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.18 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average Cyclically Adjusted Book Growth Rate was 7.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 24.10% per year. The lowest was 7.80% per year. And the median was 15.35% per year.

As of today (2026-07-12), Shanghai Fosun Pharmaceutical (Group) Co's current stock price is €1.8035. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1.18. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio of today is 1.53.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 8.43. The lowest was 1.46. And the median was 3.70.


Shanghai Fosun Pharmaceutical (Group) Co  (STU:08HH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.8035/1.18
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 8.43. The lowest was 1.46. And the median was 3.70.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Related Terms


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.96 0.94 0.91 1.13

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.97 1.27 1.13 1.18

STU:08HH vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio falls into.


STU:08HH
71GF Score
Shanghai Fosun Pharmaceutical (Group) Co Ltd STU:08HH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.31/116.3033*116.3033
=2.310

Current CPI (Mar. 2026) = 116.3033.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.109 101.400 1.272
201609 1.085 102.400 1.232
201612 1.259 102.600 1.427
201703 1.281 103.200 1.444
201706 1.292 103.100 1.457
201709 1.307 104.100 1.460
201712 1.301 104.500 1.448
201803 1.333 105.300 1.472
201806 1.357 104.900 1.505
201809 1.392 106.600 1.519
201812 1.394 106.500 1.522
201903 1.478 107.700 1.596
201906 1.438 107.700 1.553
201909 1.526 109.800 1.616
201912 1.597 111.200 1.670
202003 1.646 112.300 1.705
202006 1.617 110.400 1.703
202009 1.609 111.700 1.675
202012 1.815 111.500 1.893
202103 1.898 112.662 1.959
202106 1.908 111.769 1.985
202109 2.000 112.215 2.073
202112 2.125 113.108 2.185
202203 2.140 114.335 2.177
202206 2.106 114.558 2.138
202209 2.346 115.339 2.366
202212 2.259 115.116 2.282
202303 2.302 115.116 2.326
202306 2.193 114.558 2.226
202309 2.206 115.339 2.224
202312 2.195 114.781 2.224
202403 2.216 115.227 2.237
202406 2.251 114.781 2.281
202409 2.255 115.785 2.265
202412 2.321 114.893 2.350
202503 2.290 115.116 2.314
202506 2.143 114.907 2.169
202509 2.151 115.471 2.166
202512 2.213 115.832 2.222
202603 2.310 116.303 2.310

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.18 mean?
Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) has a Cyclically Adjusted Book per Share of €1.18 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors.
Is Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share too high?
Shanghai Fosun Pharmaceutical (Group) Co's current Cyclically Adjusted Book per Share is €1.18. Overall, Shanghai Fosun Pharmaceutical (Group) Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share of €1.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors. Shanghai Fosun Pharmaceutical (Group) Co's current Cyclically Adjusted Book per Share is €1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Fosun Pharmaceutical (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.23, compared to a current price of €1.80 — trading 19.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €1.18. Shanghai Fosun Pharmaceutical (Group) Co's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH), the current Cyclically Adjusted Book per Share is €1.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co stock appears to be undervalued. The current stock price of €1.80 is trading 19.1% below its estimated GF Value™ of €2.23. GuruFocus considers Shanghai Fosun Pharmaceutical (Group) Co to be Modestly Undervalued.

Key valuation signals for STU:08HH:

  • Cyclically Adjusted Book per Share: €1.18
  • GF Value™: €2.23 vs. price of €1.80 (19.1% below fair value)
  • GF Score™: 71/100 with 10 warning signs

No single metric tells the full story. See the STU:08HH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Address No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
71GF Score

Get the complete analysis for STU:08HH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.80
Price
€2.23
GF Value